Stocks and Investing
Stocks and Investing
Wed, May 4, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Arun Viswanathan Maintained (CC) at Buy with Increased Target to $48 on, May 4th, 2022
Arun Viswanathan of RBC Capital, Maintained "The Chemours Company" (CC) at Buy with Increased Target from $42 to $48 on, May 4th, 2022.
Arun has made no other calls on CC in the last 4 months.
There are 2 other peers that have a rating on CC. Out of the 2 peers that are also analyzing CC, all agree with Arun's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Zekauskas of "JP Morgan" Maintained at Hold with Decreased Target to $30 on, Monday, February 14th, 2022
- Joshua Spector of "UBS" Maintained at Hold with Increased Target to $36 on, Tuesday, January 4th, 2022
Contributing Sources